Teva Pharmaceutical Industries (TEVA) Short Interest Ratio & Short Volume → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free TEVA Stock Alerts $17.04 +0.16 (+0.95%) (As of 12:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Teva Pharmaceutical Industries Short Interest DataCurrent Short Volume12,220,000 sharesPrevious Short Volume11,660,000 sharesChange Vs. Previous Month+4.80%Dollar Volume Sold Short$171.45 millionShort Interest Ratio / Days to Cover1.3Last Record DateApril 30, 2024Outstanding Shares1,121,090,000 sharesPercentage of Shares Shorted1.09%Today's Trading Volume6,550,323 sharesAverage Trading Volume10,925,446 sharesToday's Volume Vs. Average60% Short Selling Teva Pharmaceutical Industries ? Sign up to receive the latest short interest report for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTEVA Short Interest Over TimeTEVA Days to Cover Over TimeTEVA Percentage of Float Shorted Over Time Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. Teva Pharmaceutical Industries Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,220,000 shares $171.45 million +4.8%N/A1.3 $14.03 4/15/202411,660,000 shares $154.26 million +0.9%N/A1.1 $13.23 3/31/202411,560,000 shares $163.11 million +10.5%N/A1.1 $14.11 3/15/202410,460,000 shares $140.53 million -28.9%N/A1 $13.44 2/29/202414,720,000 shares $193.27 million -4.4%N/A1.4 $13.13 2/15/202415,390,000 shares $202.99 million -16.0%N/A1.5 $13.19 Get the Latest News and Ratings for TEVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 1/31/202418,320,000 shares $221.67 million +9.3%N/A1.8 $12.10 1/15/202416,760,000 shares $189.72 million +2.5%N/A1.9 $11.32 12/31/202316,350,000 shares $170.69 million +15.8%N/A1.9 $10.44 12/15/202314,120,000 shares $140.92 million +6.1%N/A1.7 $9.98 11/30/202313,310,000 shares $130.77 million -6.1%N/A1.5 $9.83 11/15/202314,180,000 shares $127.19 million -18.9%N/A1.7 $8.97 10/31/202317,490,000 shares $150.06 million +19.2%N/A2.1 $8.58 10/15/202314,670,000 shares $127.04 million +8.1%N/A1.6 $8.66 9/30/202313,570,000 shares $138.41 million -19.5%N/A1.4 $10.20 9/15/202316,850,000 shares $178.10 million -0.3%N/A1.8 $10.57 8/31/202316,900,000 shares $164.94 million -18.4%N/A1.7 $9.76 8/15/202320,710,000 shares $197.47 million -8.8%N/A1.7 $9.54 7/31/202322,710,000 shares $190.65 million +18.7%N/A1.6 $8.40 7/15/202319,130,000 shares $157.06 million +18.7%N/A1.5 $8.21 6/30/202316,120,000 shares $121.30 million -24.4%N/A1.2 $7.53 6/15/202321,330,000 shares $161.68 million +0.1%N/A1.6 $7.58 5/31/202321,300,000 shares $153.15 million +52.5%N/A1.6 $7.19 5/15/202313,970,000 shares $112.74 million +9.7%N/A1.2 $8.07 4/30/202312,730,000 shares $111.13 million -16.6%N/A1.4 $8.73 4/15/202315,260,000 shares $126.51 million -7.4%N/A1.7 $8.29 3/31/202316,480,000 shares $145.85 million -15.9%N/A1.8 $8.85 3/15/202319,590,000 shares $169.85 million -23.4%N/A2.2 $8.67 2/28/202325,570,000 shares $253.40 million -7.6%N/A2.9 $9.91 2/15/202327,680,000 shares $285.38 million -2.4%N/A3.1 $10.31 1/31/202328,350,000 shares $298.81 million +13.3%N/A2.9 $10.54 1/15/202325,020,000 shares $281.22 million -20.5%N/A2.6 $11.24 12/30/202231,470,000 shares $287.01 million +31.2%N/A3.3 $9.12 12/15/202223,980,000 shares $214.86 million -22.7%N/A2.6 $8.96 11/30/202231,030,000 shares $272.13 million +0.7%N/A3.4 $8.77 11/15/202230,810,000 shares $282.84 million +2.1%N/A3.3 $9.18 10/31/202230,190,000 shares $269.29 million +3.8%N/A2.9 $8.92 10/15/202229,080,000 shares $231.19 million -0.2%N/A2.3 $7.95 9/30/202229,150,000 shares $235.24 million +12.4%N/A2.2 $8.07 9/15/202225,940,000 shares $230.61 million +28.0%N/A1.9 $8.89Look Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. TEVA Short Interest - Frequently Asked Questions What is Teva Pharmaceutical Industries' current short interest? Short interest is the volume of Teva Pharmaceutical Industries shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 12,220,000 shares of TEVA short. Learn More on Teva Pharmaceutical Industries' current short interest. What is a good short interest ratio for Teva Pharmaceutical Industries? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TEVA shares currently have a short interest ratio of 1.0. Learn More on Teva Pharmaceutical Industries's short interest ratio. Which institutional investors are shorting Teva Pharmaceutical Industries? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Teva Pharmaceutical Industries: Simplex Trading LLC, IMC Chicago LLC, and Goldman Sachs Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Teva Pharmaceutical Industries' short interest increasing or decreasing? Teva Pharmaceutical Industries saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 12,220,000 shares, an increase of 4.8% from the previous total of 11,660,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Teva Pharmaceutical Industries' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Teva Pharmaceutical Industries: BioMarin Pharmaceutical Inc. (2.06%), BeiGene, Ltd. (1.93%), Viatris Inc. (3.84%), Sarepta Therapeutics, Inc. (6.02%), Genmab A/S (0.42%), Dr. Reddy's Laboratories Limited (0.52%), United Therapeutics Co. (9.42%), Alnylam Pharmaceuticals, Inc. (2.08%), Catalent, Inc. (3.67%), Roivant Sciences Ltd. (8.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Teva Pharmaceutical Industries stock? Short selling TEVA is an investing strategy that aims to generate trading profit from Teva Pharmaceutical Industries as its price is falling. TEVA shares are trading up $0.62 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Teva Pharmaceutical Industries? A short squeeze for Teva Pharmaceutical Industries occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TEVA, which in turn drives the price of the stock up even further. How often is Teva Pharmaceutical Industries' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TEVA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BMRN Short Squeeze BGNE Short Squeeze VTRS Short Squeeze SRPT Short Squeeze GMAB Short Squeeze RDY Short Squeeze UTHR Short Squeeze ALNY Short Squeeze CTLT Short Squeeze ROIV Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:TEVA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals